JavaScript seems to be disabled in your browser.
You must have JavaScript enabled in your browser to utilize the functionality of this website.

Human Factor IX (Factor 9) AssayMax ELISA Kit (WHO Standard Calibrated Controls Included)

Human Factor IX (Factor 9) AssayMax ELISA Kit (WHO Standard Calibrated Controls Included)

Move your mouse over image or click to enlarge

Human Factor IX (Factor 9) AssayMax ELISA Kit (WHO Standard Calibrated Controls Included)

This assay employs a quantitative enzyme immunoassay technique that measures the specified antigen in samples.

View Datasheet

Cat#	Size	Price	Qty	Buy
EF1009-7	96 Well Plate	£320.94

Additional Information

Property	Value or Rating
Manufacturer	Assaypro, LLC.
Product Type	AssayMax™ ELISA Kits
Samples	Serum, Cell Culture, CSF
Species	Human
Reactivity	Human
Assay Format	Sandwich ELISA
Product Size	96 Well Plate
Range	1.56-100 ng/ml
Plex Number	1
Storage	Refer to component labels for details
Entrez Gene	2158
Omim	300746
UniProt	P00740
UniGene	Hs.522798
Special Notes	For Research Use Only, Not To Be Used For Diagnostic Purposes
References	* Dadehbeigi N et al. (2008) Sex hormones affect the production of recombinant Factor IX in CHO and HEK-293 cell lines. Biotechnol Lett. 30(11):1909-12 * Fima UE et al. (2010) Long-Acting Coagulation Factors and Methods of Producing Same. Patent No: US 8476234 B2 * Guild BC et al. (2012) Lipid nanoparticle compositions and methods for mrna delivery. Patent Application WO2012170930 A1 * Ostroff RM et al. (2012) Early detection of malignant pleural mesothelioma in asbestos-exposed individuals with a noninvasive proteomics-based surveillance tool. PLoS One. 7(10):e46091 * Derosa F et al.(2014) Lipidic nanoparticles for mrna delivering. Patent application:WO2014089486 A1 * Heartlein M (2014) Mrna therapeutic compositions and use to treat diseases and disorders. Patent application:WO2014152940 A1 " title=" * Dadehbeigi N et al. (2008) Sex hormones affect the production of recombinant Factor IX in CHO and HEK-293 cell lines. Biotechnol Lett. 30(11):1909-12 * Fima UE et al. (2010) Long-Acting Coagulation Factors and Methods of Producing Same. Patent No: US 8476234 B2 * Guild BC et al. (2012) Lipid nanoparticle compositions and methods for mrna delivery. Patent Application WO2012170930 A1 * Ostroff RM et al. (2012) Early detection of malignant pleural mesothelioma in asbestos-exposed individuals with a noninvasive proteomics-based surveillance tool. PLoS One. 7(10):e46091 * Derosa F et al.(2014) Lipidic nanoparticles for mrna delivering. Patent application:WO2014089486 A1 * Heartlein M (2014) Mrna therapeutic compositions and use to treat diseases and disorders. Patent application:WO2014152940 A1 " target="_blank"> * Dadehbeigi N et al. (2008) Sex hormones affect the production of recombinant Factor IX in CHO and HEK-293 cell lines. Biotechnol Lett. 30(11):1909-12 * Fima UE et al. (2010) Long-Acting Coagulation Factors and Methods of Producing Same. Patent No: US 8476234 B2 * Guild BC et al. (2012) Lipid nanoparticle compositions and methods for mrna delivery. Patent Application WO2012170930 A1 * Ostroff RM et al. (2012) Early detection of malignant pleural mesothelioma in asbestos-exposed individuals with a noninvasive proteomics-based surveillance tool. PLoS One. 7(10):e46091 * Derosa F et al.(2014) Lipidic nanoparticles for mrna delivering. Patent application:WO2014089486 A1 * Heartlein M (2014) Mrna therapeutic compositions and use to treat diseases and disorders. Patent application:WO2014152940 A1

Related Documents